Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence
Baron-Papillon
President (Sanofi)
Juan Carlos
Jaramillo
Vice-President (Valneva)
Andreas
Potthoff
(Abbott)
Lorenzo
Wittum
(AstraZeneca)
Sharon
McHale
(CSL Seqirus)
Guillermo
De Juan Echávarri
(GSK)
Lydia
Ogden
(Johnson & Johnson)
Alexander
Meier
(Moderna)
Nicoletta
Luppi
(MSD)
Kelly
Cappio
(Novavax)
Tobias
Cousens
(Pfizer)

Executive office

Sibilia
Quilici
Executive Director
Laurent
Louette
Director, Public Affairs & Country Liaison
Anna
Czwarno
Director, Regulatory, Manufacturing & Supply
Charlotte
Vernhes
Director, Scientific and Medical Affairs
Anna
Vicere
Associate Director, Public Affairs & Access Policy
Andreea
Iordache
Manager, Science & Regulatory Affairs
Polina
Zoteva
Communications Lead
Anne
Meynaerts
Administrative Assistant

Working Group Chairs